2022/09/07

For the third consecutive year ANNAIDA is selected among the Top100 Swiss startups. 

2021/02/01

Annaida awarded the highly competitive EIC-SME INSTRUMENT PHASE 2 Grant* by the EU. The grant supports innovative SMEs in developing novel solutions with a strong social impact. Annaida will use the funds to accelerate product development and safety validation, bringing its breakthrough device closer to market.

*Grant number 959600

2020/04/09

We are proud to finally announce the closure of an oversubscribed financing round of CHF 1M. A big thank you goes to our investors: HEMEX AG, Fongit Seed Invest, Zürcher Kantonalbank, Business Angels Switzerland, Privilège Ventures, Venture Kick and an angel. Even in these complicated times Switzerland continues to believe and invest in innovation.

2020/03/11

Annaida has been selected in the among the Top16 by de Vigier Stiftung for the 2020 W.A. We are honored to be participating to this prestigious award!

2019/09/12

Annaida receives support by Innosuisse for the first trial on human embryos in collaboration with CPMA, the largest IVF clinics in Switzerland. With this support we can now grow our team and go to next mile: Thank you Innosuisse!

2019/08/23

Annaida successfully passed the Innosuisse initial coaching report and has now obtained further budget to access Innosuisse coaching.

2019/07/30

Annaida was selected for the AIT Brazil 2019 program. The selected startups will travel to S. Paulo and Rio de Janeiro in November for an exciting training camp. Looking forward to it!

2019/05/01

Annaida Technologies SA closes a pre-seed round of 140’000 CHF with two investors. The round is led by Hemex AG, that brings capital and expertise in MedTech and financing. Pascal Winnen (CEO of Hemex) joins the Board of Directors of Annaida. Ready for next stage!

2019/05/01

We are glad to announce that Annaida won VentureKick stage III, one of the most competitive competition for startups in Switzerland. Thanks to VentureKick we can now speed up our business and product development, as well as define collaborations with partners that are important for our mission. With stage III, VentureKick invested in Annaida 130’000 CHF.

2019/03/20

Phase 1! The EmbryoSpin project by Annaida has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 836962. Thanks to these funds we developed important partnerships that will be at the base of our future operation. We are now eligibile for Phase 2 H2020 projects!